✦ LIBER ✦

P-266 Clinical evaluation of long-term intermittent administration of interferon-alfa in patients with HBe antigen-positive or negative chronic hepatitis B

✍ Scribed by Yukiya Hakozaki; Toshirou Kondou

Book ID: 113402151
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 119 KB
Volume: 3
Category: Article
ISSN: 0928-4346
DOI: 10.1016/0928-4346(95)90562-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term intermittent administration of

Long-term intermittent administration of interferon-α in patients with chronic non-A, non-B hepatitis

✍ Ito, Toshio ;Sue, Kunihiko ;Kakio, Takeshi ;Muguruma, Mitsuru ;Tsuji, Takao ;Ter 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 823 KB

Long-term effects of interferon-α in fiv

Long-term effects of interferon-α in five HIV-positive patients with chronic hepatitis B

✍ V. di Martino; F. Lunel; J.F. Cadranel; C. Hoang; Y. Parlier; Y. Le Charpentier; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 818 KB

Long-term outcomes of thymosin-α1 and in

Long-term outcomes of thymosin-α1 and interferon α-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B

✍ Murat Saruc; Nuri Ozden; Nurten Turkel; Semin Ayhan; Lynette M. Hock; Isil Tuzcu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 1 views

Hepatitis B e antibody (HbeAb) and hepatitis B virus (HBV) DNA positive chronic hepatitis is a clinical entity, distinct from classical hepatitis B e antigen (HbeAg) positive chronic hepatitis B. Our aim was to evaluate the long-term therapeutic efficacy of the combination of interferon alpha-2b and

A randomized controlled trial of thymosi

A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody-and hepatitis B virus DNA-positive chronic hepatitis B

✍ P Andreone; C Cursaro; A Gramenzi; C Zavaglia; I Rezakovic; E Altomare; R Severi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

A randomized controlled trial of thymosi

A randomized controlled trial of thymosin-α1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody—and hepatitis B virus DNA—positive chronic hepatitis B

✍ P Andreone; C Cursaro; A Gramenzi; C Zavaglia; I Rezakovic; E Altomare; R Severi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

ment for anti-HBe-positive chronic hepatitis. The benefit It has recently been shown that thymosin-a 1 (T-a 1 ), a of this agent in producing long-term inhibition of HBV synthetic polypeptide of thymic origin, is able to proreplication must be confirmed by future trials. (HEPAmote disease remission

Long-term follow-up of interferon alfa t

Long-term follow-up of interferon alfa treatment in chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications

✍ Man-Fung Yuen; Chee-Kin Hui; Chi-Chung Cheng; Chi-Hang Wu; Yim-Ping Lai; Ching-L 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB